Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 19.96
+0.16 (0.81%)
Sep 25, 2026, 11:10 AM CET
Celon Pharma Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 257.64 | 242.21 | 205.55 | 214.66 | 193.89 | 196.09 |
Revenue Growth | 24.94% | 17.83% | -4.25% | 10.72% | -1.12% | 24.54% |
Gross Profit Gross Profit Growth | 197.64 | 174.28 | 142.38 | 147.85 | 127.42 | 134.37 |
Operating Income Operating Income Growth | -4.9 | -25.02 | -52.94 | -28.35 | -37.9 | -10.59 |
Net Income Net Income Growth | 106.81 | -79.36 | -34.45 | -28.12 | -39.28 | -11.61 |
Earnings Per Share EPS Growth | 2.04 | -1.49 | -0.64 | -0.55 | -0.77 | -0.25 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Generic medicines Generic medicines Growth | 209.03 | 206.25 | 176.62 | 164.39 | 161.92 | 169.56 |
Innovative Innovative Growth | 51.33 | 38.09 | 27.44 | 49.53 | 31.97 | 26.53 |
Total Total Growth | 260.36 | 244.34 | 204.05 | 213.92 | 193.89 | 196.09 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 34.54 | 19.91 | 75.09 | 114.54 | 164.62 | 227.55 |
Total Debt Total Debt Growth | 128.44 | 18.94 | 16.93 | 25.59 | 26.82 | 14.92 |
Net Cash (Debt) Net Cash Growth | -93.91 | 0.97 | 58.16 | 88.95 | 137.8 | 212.63 |
Net Cash Growth | - | -98.34% | -34.62% | -35.45% | -35.19% | 1049.56% |
Net Cash Per Share Net Cash Per Share Growth | -1.79 | 0.02 | 1.08 | 1.74 | 2.70 | 4.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 27.29 | 23.85 | -11.34 | -8.31 | -4.7 | 43.95 |
Capital Expenditures CapEx Growth | -83.92 | -54.44 | -22.79 | -32.81 | -33.91 | -41.35 |
Free Cash Flow Free Cash Flow Growth | -56.63 | -30.58 | -34.13 | -41.13 | -38.61 | 2.6 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 76.71% | 71.95% | 69.27% | 68.87% | 65.72% | 68.53% |
Operating Margin | -1.90% | -10.33% | -25.75% | -13.21% | -19.55% | -5.40% |
Pretax Margin | 55.74% | -24.35% | -19.15% | -9.30% | -18.80% | -7.69% |
Profit Margin | 41.46% | -32.77% | -16.76% | -13.10% | -20.26% | -5.92% |
FCF Margin | -21.98% | -12.63% | -16.61% | -19.16% | -19.91% | 1.33% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.080 | 0.090 | 0.290 |
Dividend Per Share Growth | -11.11% | -68.97% | 314.29% |
Dividend Yield | 0.52% | 0.65% | 0.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 24.15 | 35.84 | 72.92 | 72.92 | 72.92 |
P/FCF Ratio | - | - | - | - | - | 650.25 |
PS Ratio | 4.14 | 4.53 | 6.93 | 3.68 | 3.69 | 8.62 |